(Q73028966)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

0 references

J J Drabick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

B L Brandt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E E Moran

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

N B Saunders

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D R Shoemaker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

W D Zollinger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

160-172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Isolation and Characterization of a Native Cell Wall Complex from Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Human immunity to the meningococcus. II. Development of natural immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that r

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900216-9

7 January 2021

10.1016/S0264-410X(99)00216-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501246%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference